Puma Biotechnology | PBYI - Capitalização De Mercado





Capitalização De Mercado Alterar Data
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Exelixis USD 10.89B 857M 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
Glaxosmithkline GBP 108.55B 736M 2026-07
Incyte USD 18.73B 660M 2026-03
MacroGenics USD 287M 103M 2026-07
Moderna USD 20.15B 8.53B 2026-03
Novartis USD 307.76B 15.54B 2026-03
Pfizer USD 153.81B 12.24B 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.28B 30M 2026-03
Takeda JPY 9.01T 1.37T 2026-03
TG Therapeutics USD 5.31B 572M 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Vanda Pharmaceuticals USD 279M 6M 2024-12
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03